Module home
Module introduction
Pre-module test
Module information
About the authors
Section 1: Definition and
implications
(1.1) Section 1: Definition and implications
(1.2) Definition
(1.3) Problems in evaluating studies
(1.4) Problems in evaluating studies
(1.5) The size of the problem
(1.6) The size of the problem
(1.7) The size of the problem
(1.8) The size of the problem
(1.9) National policy in the UK: The National Institute for
Clinical Excellence (NICE)
(1.10) National policy in the UK: The National Institute for
Clinical Excellence (NICE)
(1.11) Self-harm that is not assessed
(1.12) National policy in the UK: The Department of Health’s
National Suicide Prevention Strategy for England
(1.13) National policy in the UK: The Department of Health’s
National Suicide Prevention Strategy for England
(1.14) National policy in Ireland
(1.15) Section 1: Recap
(1.16) Section 1:
Summary
Section 2: Presenting the
evidence
(2.1) Section 2: Presenting the evidence
(2.2) Presenting the evidence
(2.3) Continuing contact
(2.4) Continuing contact
(2.5) Continuing contact
(2.6) Continuing contact
(2.7) Emergency card
(2.8) New developments
(2.9) Cognitive therapy
(2.10) Cognitive therapy
(2.11) Cognitive therapy
(2.12) Focal psychotherapy
(2.13) Dialectical behaviour therapy
(2.14) Dialectical behaviour therapy
(2.15) Dialectical behaviour therapy
(2.16) Primary care-based interventions
(2.17) Psychoanalytical psychotherapy
(2.18) Manualised cognitive-behaviour therapy
(2.19) Combined approaches
(2.20) Section 2: Recap 1
(2.21) Intensive in-patient and community intervention
(2.22) Cochrane review of psychosocial and pharmacological
treatments for self harm
(2.23) Adolescents and young adults
(2.24) Section 2: Recap 2
(2.25) Section 2:
Summary
Section 3: Practical
applications
(3.1) Section 3: Practical applications
(3.2) Who should deliver assessment and treatment?
(3.3) Treatment algorithms for reducing repetition of
self-harm
(3.4) Guideline 1 - adults 18–65
(3.5) Guideline 2 - adults 18–65
(3.6) Guideline 3 - women with borderline personality
disorder
(3.7) Guideline 4 – women with borderline
personality disorder
(3.8) Guideline 5 – men and women with
borderline personality disorder
(3.9) Guideline 6 – men and women with
recurrent self harm
(3.10) Section 3: Recap
(3.11) Section 3:
Summary
Module
summary
Module test
Take-home notes
References
Send feedback
Annual
revisions
Annual revisions
|